window.dataLayer = window.dataLayer || []; (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-5L46PPF2');

EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

FT 09 - Flash talks on Real World Evidence

Saturday 01 Jun, 08:30 AM - 10:00 AM Valencia, Spain
Cordoba Flash Talks
08:30
Long-term allergic diseases outcomes in long COVID: multinational population-based cohort studies from South Korea, Japan and the UK
08:37
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
08:44
Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study
08:51
Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics
08:58
Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted olive-grasses allergen extract
09:05
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS
09:12
Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis
09:19
How, when and why AIT is prescribed in Italy: a real-life study conducted through a patient association
09:26
Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry
09:33
Real-world effectiveness of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is independent of comorbidities, sinus surgery history and level of type 2 inflammation: Findings from CHRINOSOR
09:40
An unselected case cohort from the United Kingdom Fatal Anaphylaxis Registry

Chairs

Speakers